N-(1-OXO-4Z,7Z,10Z,13Z,16Z,19Z-DOCOSAHEXAENYL)-GLYCINE structure
|
Common Name | N-(1-OXO-4Z,7Z,10Z,13Z,16Z,19Z-DOCOSAHEXAENYL)-GLYCINE | ||
---|---|---|---|---|
CAS Number | 132850-40-9 | Molecular Weight | 385.54 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 582.1±50.0 °C at 760 mmHg | |
Molecular Formula | C24H35NO3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 305.9±30.1 °C |
Use of N-(1-OXO-4Z,7Z,10Z,13Z,16Z,19Z-DOCOSAHEXAENYL)-GLYCINEDocosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs?channels?and restore the function of IKs?channels with LQT1 mutation[1]. |
Name | 2-(docosa-4,7,10,13,16,19-hexaenoylamino)acetic acid |
---|---|
Synonym | More Synonyms |
Description | Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs?channels?and restore the function of IKs?channels with LQT1 mutation[1]. |
---|---|
Related Catalog | |
Target |
IC50: IKs?Channel[1] |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 582.1±50.0 °C at 760 mmHg |
Molecular Formula | C24H35NO3 |
Molecular Weight | 385.54 |
Flash Point | 305.9±30.1 °C |
Exact Mass | 385.261688 |
PSA | 66.40000 |
LogP | 5.65 |
Vapour Pressure | 0.0±3.5 mmHg at 25°C |
Index of Refraction | 1.526 |
Glycine, N-[(4Z,7Z,10Z,13Z,16Z,19Z)-1-oxo-4,7,10,13,16,19-docosahexaen-1-yl]- |
N-[(4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-Docosahexaenoyl]glycine |